Top entities: KC Pharmaceuticals, Jefferies, Goldman Sachs, Jack A. Khattar, Timothy C. Dec.

What category does this event fall under?

Business — classified as investor conference.

What is the sentiment of coverage?

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This is an active story, last updated May 27, 2026. Coverage continues to evolve.

Business investor conference

Supernus Pharmaceuticals to attend investor conferences

Q: When did this event occur?

First reported May 27, 2026; last updated May 27, 2026.

Q: What is the market impact?

Direct. The participation of KC Pharmaceuticals in these investor conferences could lead to increased investor awareness and potentially a positive impact on the company's stock price.

Analysis based on 6 articles · First reported May 27, 2026 · Last updated May 27, 2026

Sentiment

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The participation of KC Pharmaceuticals in these investor conferences could lead to increased investor awareness and potentially a positive impact on the company's stock price. It provides an opportunity for KC Pharmaceuticals to communicate its strategy and performance to a broader investor base.

Pharmaceuticals Biotechnology

Event Summary

KC Pharmaceuticals, a biopharmaceutical company specializing in central nervous system diseases, announced its management will participate in two investor conferences in June 2026. These include the 2026 Jefferies Global Healthcare Conference on June 3, 2026, in New York, NY, and the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, in Miami Beach, Fla. The company's President and CEO, Jack A. Khattar, and Senior Vice President and CFO, Timothy C. Dec, will represent KC Pharmaceuticals. A live audio webcast of the Jefferies conference will be available, with archived replays for 60 days.

Key Actions

100 KC Pharmaceuticals will present

Entities Involved

priv

KC Pharmaceuticals

KC Pharmaceuticals will participate in two investor conferences in June 2026, providing an opportunity to engage with investors and potentially increase visibility and investor interest in the company.

Importance 100 Sentiment 10

priv

Jefferies

Jefferies is hosting the 2026 Jefferies Global Healthcare Conference, where KC Pharmaceuticals will participate.

Importance 40 Sentiment 0

stock

Goldman Sachs

Goldman Sachs is hosting the 47th Annual Global Healthcare Conference, where KC Pharmaceuticals will participate.

Importance 40 Sentiment 0

per

Jack A. Khattar

Jack A. Khattar, President and CEO of KC Pharmaceuticals, is part of the management team that will participate in the investor conferences.

Importance 30 Sentiment 0

per

Timothy C. Dec

Timothy C. Dec, Senior Vice President and CFO of KC Pharmaceuticals, is part of the management team that will participate in the investor conferences.

Importance 30 Sentiment 0

per

Peter Vozzo

Peter Vozzo is the investor contact for KC Pharmaceuticals through ICR Healthcare.

Importance 10 Sentiment 0

priv

ICR Healthcare

ICR Healthcare is the investor contact for KC Pharmaceuticals.

Importance 10 Sentiment 0

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard